Capitol Health : 1H2022 Results Presentation

HY 2022 RESULTS

Half Year Ended 31 December 2021

Justin Walter - Chief Executive Officer & Managing Director Craig Bremner - Chief Financial Officer

TABLE OF CONTENTS

1. Highlights
2. Financials
3. Growth
4. Appendix

For further information please contact Craig Bremner | CFO | [phone] | [e-mail]

2

01. HIGHLIGHTS

HY 2022 RESULTS SUMMARY

REVENUE

$94.8m

Up 11.2% pcp

FREE CASH FLOW *

$12.9m

Down 3.5% pcp*

OPERATING EBITDA *

$22.2m

Up 6.9% pcp*

NET DEBT / LTM OPERATING EBITDA

< 0.1x

OPERATING EBITDA MARGIN *

23.4%

Down from 24.4% pcp*

INTERIM DPS

0.5 cps

Fully franked

• The government Jobkeeper funding of $5.8m recognised as an offset to employee expenses in HY21 prior to tax, has been excluded from previous comparative period calculations.

4

HY 2022 HIGHLIGHTS

Key Financial Highlights

• Revenue from operations of $94.8m up 11.2% on pcp
• Underlying organic growth rate of revenue of 5.8% pcp
• Total Operating Costs up 12.6% on pcp (ex Jobkeeper) to $72.6m
• Operating EBITDA increased by 6.9% on pcp (ex Jobkeeper) to $22.2m
• Operating Margin of 23.4% is down from 24.4% pcp (ex Jobkeeper)
• Statutory NPAT up 30.2% to $8.1m
• Net Debt below 0.1x annualised Operating EBITDA
• Interim dividend FY22 maintained at 0.5 cents per share fully franked
• $4.2m of Radiologist options exercised.

• Operating excludes Transaction & Restructure Costs, Unrealised Foreign Exchange Gain/(Loss), Impairment of Financial Asset and Financial Liabilities movement in fair value.

5